Cite Filings / NRIX / 0000902664-26-002545
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Nurix Therapeutics, Inc. · Filed 2026-05-15 · Acc 0000902664-26-002545

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-07-31 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-15 4 Options or other derivatives
  • 2026-05-15 4 Options or other derivatives
  • 2026-05-15 8-K Shareholder vote results
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-06 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 5.49%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.55%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.4%
  5. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.4%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…